Summary
The aim of this work was to use radiopharmaceuticals such as technetium (99mTc) and indium (DTPA-CA-111In) to visualize, with a gamma-camera, the disintegration area and time of 3 types of enteric coated hard gelatin capsules (obtained by 3 different preparation processes) and thus, to verify that they are really resistant in gastric fluids and soluble in intestinal zones. Results are well correlated with those previously obtained in vitro (disintegration, dissolution) and in vivo (profiles of plasmatic concentrations versus time).
Similar content being viewed by others
References
Tonami N., Nakajima K., et al. (1988): Observation of portal circulation through superior mesenteric vein by enteric coated capsule of thallium-201, Eur. J. Nucl. Med., 14, 147–151.
Casey D., Beihn R., Digenis G., Shambhu M. (1976): Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy. J. Pharm, Sci., 65, 1412–1413.
Theodorakis M., Devous M., Simpson D. (1980): Monitoring in vivo disintegration time of tablets by external scintigraphy, J. Pharm. Sci., 69, 1107–1108.
Kaus L., Sharma H., Fell J.T. (1984): Simultaneous measurement of gastric emptying of the soluble and insoluble components of a formulation using a dual isotope, gamma scintigraphic technique, J. Pharm. Pharmacol., 36, 136–138.
Christensen F.N., Davis S.S., Hardy J.G., Taylor M.J., Whalley D.R., Wilson C.G. (1985): The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations, J. Pharm. Pharmacol., 37, 91–95.
Maublant J., Sournac M., Aiache J-M., Veyre A. (1987): Dissolution rate and transit times of technetium-99m DTPA-labelled tablets, J. Nucl. Med., 28, 1199–1203.
Wilson C.G., Washington N. (1988): Assessment of disintegration and dissolution of dosage forms in vivo using gamma scintigraphy, Drug Devel. Ind. Pharm., 14, 211–281.
Barthélémy C., Robert H., Ringard-Lefebvre C., Guyot-Hermann A-M. (1990): Vérification in vivo de la fiabilité des procédés «officinaux» de préparation des gélules gastrorésistantes. Pharm. Hosp. Fr., 91, 1179–1187.
Laboratoire des gélules et des azymes. Documentation LGA, 6 rue d’Andrezel BP 17, 77720 Mormant, France.
Société Gheysen, documentation Cercap®, Brevet Belge no. 721.689, Brugzavel 48, 9690 Kluisbergen, Belgium.
Ter Horst H.J., Van Drunen J.R. (1989): De ‘capsule coater’ een apparaat voor de bereinding van maagsapresistente capsules in de apotheek, Pharm. Weekbl., 124, 530–538.
Siegel J.A., Wu R.K., Knight L.C., Zelac R.E., Stern H.S., Malmud L.S. (1983): Radiation dose estimates for oral agents used in upper gastrointestinal disease, J. Nucl. Med., 24, 835.
Lecouffe P., Fontaine P., Foucher C., et al. (1987): Etude isotopique de la vidange gastrique chez des patients atteints d’hypoglycémies fontionnelles, J. Fr. Biophys., 11 (Suppl. 2), 198–200.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Catteau, D., Barthélémy, C., Deveaux, M. et al. Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules. Eur. J. Drug Metab. Pharmacokinet. 19, 91–98 (1994). https://doi.org/10.1007/BF03188829
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03188829